celgeneriskmanagement.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Celgene Risk |
| Description | Welcome to the REMS Program Administered by Celgene To avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs are mandatory |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.170.161 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
celgeneriskmanagement.com Valuation
|
US$37,644,053
Last updated: 2022-07-11 16:00:39
celgeneriskmanagement.com has Semrush global rank of 281,168. celgeneriskmanagement.com has an estimated worth of US$ 37,644,053, based on its estimated Ads revenue. celgeneriskmanagement.com receives approximately 4,343,545 unique visitors each day. Its web server is located in United States, with IP address 45.60.170.161. According to SiteAdvisor, celgeneriskmanagement.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$37,644,053 |
| Daily Ads Revenue | US$34,749 |
| Monthly Ads Revenue | US$1,042,451 |
| Yearly Ads Revenue | US$12,509,409 |
| Daily Unique Visitors | 289,570 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| celgeneriskmanagement.com. 28795 IN | A | IP: 45.60.170.161 | |
| celgeneriskmanagement.com. 28795 IN | A | IP: 45.60.150.161 | |
| celgeneriskmanagement.com. 28800 IN | NS | NS Record: ns1.bms.com. | |
| celgeneriskmanagement.com. 28800 IN | NS | NS Record: ns2.bms.com. | |
| celgeneriskmanagement.com. 28800 IN | NS | NS Record: ns3.bms.com. | |
| celgeneriskmanagement.com. 28800 IN | NS | NS Record: ns4.bms.com. | |
| celgeneriskmanagement.com. 28800 IN | MX | MX Record: 10 custmx.cscdns.net. | |
| celgeneriskmanagement.com. 28800 IN | TXT | TXT Record: globalsign-domain-verification=7AAED19036242EA179D3B2BB78BFA414 | |
| celgeneriskmanagement.com. 28800 IN | TXT | TXT Record: v=spf1 a ptr a:email.celgene.com -all |
HtmlToTextCheckTime:2022-07-11 16:00:39
| Welcome to the REMS Program Administered by Celgene To avoid embryo-fetal exposure, Risk Evaluation and Mitigation Strategy (REMS) programs are mandatory for the REMS products THALOMID ® (thalidomide), REVLIMID ® (lenalidomide), lenalidomide and POMALYST ® (pomalidomide). The THALOMID REMS ® program, Lenalidomide REMS program and POMALYST REMS ® program require prescribers and pharmacists to be certified and patients to enroll and comply with all of the requirements for each program. If you would like to obtain more information about any of the Celgene-administered REMS programs, please click on the program name below: Visit www.LenalidomideREMS.com , to learn more about the Lenalidomide REMS program. Visit www.POMALYSTREMS.com , to learn more about the POMALYST REMS ® program. Visit www.THALOMIDREMS.com , to learn more about the THALOMID REMS ® program. For prescribers, please enter your User Name and Password to manage your patients through a Celgene-administered REMS program. If |
celgeneriskmanagement.com Whois Information
Domain Name: CELGENERISKMANAGEMENT.COM Registry Domain ID: 1688327306_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2020-12-12T03:04:28Z Creation Date: 2011-11-21T22:05:36Z Registry Expiry Date: 2021-11-21T22:05:36Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BMS.COM Name Server: NS2.BMS.COM Name Server: NS3.BMS.COM Name Server: NS4.BMS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T21:50:03Z <<< |